Clinical trial / 2015
Creatine supplementation lowered plasma guanidinoacetate but did not reduce plasma homocysteine.
A 12-week randomized trial assigned 458 Bangladeshi adults to placebo, 3 g/d creatine, 400 μg/d folic acid, or creatine plus folic acid. Creatine decreased plasma guanidinoacetate by 10.6% (95% CI: 4.9, 15.9) compared to placebo and by 9.0% (95% CI: 3.4, 14.2) with folic acid versus folic acid alone. However, creatine did not significantly change plasma total homocysteine compared to controls.
- Study type
- Randomized controlled trial
- Who was studied
- 458 adults in Bangladesh
- What was measured
- Plasma guanidinoacetate and total homocysteine
THE PAPER
Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial.
Peters BA, Hall MN, Liu X, Parvez F, Siddique AB, Shahriar H, Uddin MN, Islam T, Ilievski V, Graziano JH, Gamble MV. J Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.